Sponsored By

When evaluating a company's price for a merger or acquisition, it's important to look at more than revenue, according to Todd Harrison, Esq., attorney, Venable LLP, who has helped health and nutrition brands manage merges and acquisitions (M&As) for more than 20 years. What's just as important as revenue, he says, is the company's regulatory risk.

When evaluating a company’s price for a merger or acquisition, it’s important to look at more than revenue, according to Todd Harrison, Esq., attorney, Venable LLP, who has helped health and nutrition brands manage merges and acquisitions (M&As) for more than 20 years. What’s just as important as revenue, he says, is the company’s regulatory risk. In this podcast with Sandy Almendarez, editor in chief, INSIDER, Harrison, covers:

  • What a company should do before it puts itself on the market

  • What a company should do before it seeks to purchase a different company

  • The regulatory hurdles that can hurt the valuation and doom a potential deal

Harrison is speaking at the SupplySide West Panel Discussion, “Navigating the Business of the Nutraceutical Industry” on Thursday, Sept. 28 at 9:00 to 11:00 a.m. Visit supplysideshow.com for more information and to get registered.

About the Author(s)

Sandy Almendarez

editor in chief, Informa

Sandy Almendarez entered the natural products industry in 2009 when she joined Virgo Publishing (now Informa Exhibitions) as an assistant editor. Since then, she's worked her way up to editor in chief where she writes, edits and manages content for INSIDER. Under Sandy’s direction, INSIDER has won editorial awards from Folio: every year since 2014, including B2B Editorial Team of the Year in 2015.

Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.

You May Also Like